The Nobel Prize for medicine for telomere biology and relevance to heart failure research

European Journal of Heart Failure

Volumn 11, Issue 12, 2009, Pages 1113-1115

  Van Der Harst, Pim ^a   De Boer, Rudolf A ^a   Van Veldhuisen, Dirk J ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AWARDS AND PRIZES; CARDIOVASCULAR RISK; CELL DIVISION; CLINICAL FEATURE; DISEASE SEVERITY; DNA REPLICATION; EDITORIAL; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MEDICAL RESEARCH; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; TELOMERE;

GENETICS; HEART FAILURE; HISTORY, 21ST CENTURY; HUMANS; NOBEL PRIZE; TELOMERE;

EID: 72949088850     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfp163     Document Type: Editorial

References (20)

1. Witkowski JA. Alexis Carrel and the mysticism of tissue culture. Med Hist 1979; 23:279-296.
2. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res 1961;25:585-621.
3. Blackburn EH, Gall JG. A tandemly repeated sequence at the termini of the extra-chromosomal ribosomal RNA genes in Tetrahymena. J Mol Biol 1978;120:33-53.
4. Szostak JW, Blackburn EH. Cloning yeast telomeres on linear plasmid vectors. Cell 1982;29:245-255.
5. Greider CW, Blackburn EH. Identification of a specific telomere terminal trans-ferase activity in Tetrahymena extracts. Cell 1985;43:405-413.
6. Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, DePinho RA, Greider CW. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 1997;91:25-34.
7. Azzalin CM, Reichenbach P, Khoriauli L, Giulotto E, Lingner J. Telomeric repeat containing RNA and RNA surveillance factors at mammalian chromosome ends. Science 2007;318:798-801.
8. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2008;10:933-989.
9. Wong LS, de Boer RA, Samani NJ, van Veldhuisen DJ, van der Harst P. Telomere biology in heart failure. Eur J Heart Fail 2008;10:1049-1056.
10. Wong LS, Oeseburg H, de Boer RA, van Gilst WH, van Veldhuisen DJ, van der HP. Telomere biology in cardiovascular disease: the TERC-/-mouse as a model for heart failure and ageing. Cardiovasc Res 2009;81:244-252.
11. Collerton J, Martin-Ruiz C, Kenny A, Barrass K, von Zglinicki T, Kirkwood T, Keavney B. Telomere length is associated with left ventricular function in the oldest old: the Newcastle 85+ study. Eur Heart J 2007;28:172-176.
12. Samani NJ, van der Harst P. Biological ageing and cardiovascular disease. Heart 2008;94:537-539.
13. Brouilette SW, Moore JS, McMahon AD, Thompson JR, Ford I, Shepherd J, Packard CJ, Samani NJ. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet 2007;369:107-114.
14. van der Harst P, van der Steege G, de Boer RA, Voors AA, Hall AS, Mulder MJ, van Gilst WH, van Veldhuisen DJ. Telomere length of circulating leukocytes is decreased in patients with chronic heart failure. J Am Coll Cardiol 2007;49: 1459-1464.
15. van der Harst P, de Boer RA, Samani NJ, Wong LS, Huzen J, Codd V, Hillege HL, Voors AA, van Gilst WH, Jaarsma T, van Veldhuisen DJ. Telomere length and outcome in heart failure. Ann Med 2009; doi:10.3109/07853890903233887.
16. van der Harst P, Wong LS, de Boer RA, Brouilette SW, van der SG, Voors AA, Hall AS, Samani NJ, Wikstrand J, van Gilst WH, van Veldhuisen DJ. Possible association between telomere length and renal dysfunction in patients with chronic heart failure. Am J Cardiol 2008;102:207-210.
17. Chimenti C, Kajstura J, Torella D, Urbanek K, Heleniak H, Colussi C, Di Meglio F, Nadal-Ginard B, Frustaci A, Leri A, Maseri A, Anversa P. Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure. Circ Res 2003;93:604-613.
18. Oh H, Wang SC, Prahash A, Sano M, Moravec CS, Taffet GE, Michael LH, Youker KA, Entman ML, Schneider MD. Telomere attrition and Chk2 activation in human heart failure. Proc Natl Acad Sci USA 2003;100:5378-5383.
19. Leri A, Franco S, Zacheo A, Barlucchi L, Chimenti S, Limana F, Nadal-Ginard B, Kajstura J, Anversa P, Blasco MA. Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation. EMBO J 2003;22:131-139.
20. Huzen J, van Veldhuisen DJ, van Gilst WH, van der Harst P. Telomeres and biological ageing in cardiovascular disease. Ned Tijdschr Geneeskd 2008;152: 1265-1270. (Pubitemid 351807196)